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b Department of Otorhinolaryngology, PLA General Hospital, Beijing 100853, ChinaAbstractObjective: Based on the clinical manifestations of a hearing loss patient, the POU3F4 gene was tested for diagnosis of etiology.
Methods: A comprehensive physical examination was performed on the proband to exclude abnormalities of other organs, and detailed audi-
ological testing and temporal bone CT scan were also performed. Genomic DNAwas extracted using the proband's peripheral blood leukocytes.
Polymerase chain reactions (PCR) were performed in the coding sequence of the POU3F4 gene. Direct DNA sequencing was subsequently
applied to screen the entire coding region of the POU3F4 gene.
Results: The proband had severe sensorineural hearing loss. Temporal CT showed bilateral cochlear incomplete partition, vestibule dysplasia,
internal auditory canal fundus expansion, and cochlear interlink with the internal auditory canal fundus. A novel mutation (c.530C > A
(p.S177X)) in the POU3F4 gene was found in this patient, creating an new stop codon and was predicted to result in a truncated protein lacking
normal POU3F4 transcription factor function.
Conclusion: Through analysis of the POU3F4 gene and clinical manifestations in the patient, we conclude that a novel mutation may have
resulted in a premature stop codon, contributing to the mutation of POU3F4 gene.
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Non-syndromic hearing impairment (NSHI) is a common
defect in human, and most cases of NSHI are attributable to
genetic factors (Morton and Nance, 2006). The inheritance
patterns of NSHI include autosomal dominant (22%), auto-
somal recessive (77%), X-linked and Y-linked (~1%), and
mitochondrial inheritances (~1%) (Morton, 2002; Petersen
et al., 2008). While most genetic NSHI is caused by muta-
tions in autosomal genes, X-linked deafness account for
approximately 1%e2% of cases of hereditary hearing loss. To
date, 4 genes have been implicated in X-linked NSHI,* Corresponding author.
E-mail address: bangqing6@163.com (B.-q. Huang).
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Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://crincluding the POU3F4 (de Kok et al., 1995a), COL4A6 (Rost
et al., 2014), PRPS1 (Liu et al., 2010) and SMPX (Huebner
et al., 2011).
X-linked deafness type 2 (DFNX2) is found in ~50% of all
families carrying X-linked non-syndromic hearing loss
(Petersen et al., 2008). Clinical characteristics of DFNX2 in
affected males include partial hypoplasia of cochlea, enlarged
internal acoustic canal and a characteristic stapes gusher upon
surgery and stapes fixation (Cremers et al., 2002; de KoK
et al., 1995b). Anatomical anomalies of the temporal bone
revealed by computer-assisted tomography (CT) include
dilatation of the lateral end of the internal acoustic canal,
abnormally wide communication between the internal acoustic
canal and inner ear compartment, and, sometimes, partial
hypoplasia of the cochlea (Phelps et al., 1991). As a result of
the widening of the internal acoustic canal, cerebrospinal fluidgy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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phenomenon, described as fluid gushing out upon removal of
the stapes footplate during corrective surgery (Cremers et al.,
2008). Female carriers of a mutation in the DFNX2 show little
or no hearing loss (Petersen et al., 2008).
DFNX2 is associated with mutation in the POU3F4 gene
(de Kok et al., 1995a). Human POU3F4 is located on chro-
mosome Xq21.1, and has only one exon (1491 bp) with an
open reading frame (ORF) length of 1083 bp, coding 361
amino acids. POU3F4 is a transcription factor and belongs to a
superfamily of POU domain transcription factor. This domain
consists of a POU-specific domain (containing 76e78 amino
acids) and a POU homeodomain (containing 60 amino acids)
(Andersen and Rosenfeld, 2001). POU superfamily genes are
very important for organ formation and cell differentiation,
and the POU3F4 is closely associated with inner ear devel-
opment (de Kok et al., 1995a). Mutation of POU3F4 can cause
hearing loss, with clinical findings in audiology and on tem-
poral bone CT scan, and during stapes surgeries. Patients with
POU3F4 mutations can display conductive, mix or sensori-
neural deafness.
In this paper, we report a novel mutation in the POU3F4
gene identified in a Chinese family carrying X-linked hered-
itary hearing loss and its associated clinical characteristics in
affected family members.
2. Materials and methods2.1. SubjectThe proband came from Hainan province e a 9 years old
boy, with a weight of 20 kg and height of 123 cm. The boy was
born with hearing loss. This study was approved by the Chi-
nese PLA General Hospital Research Ethics Committee and
informed consent was obtained from the proband's parents.2.2. PhenotypeThe medical history of the proband was obtained using a
questionnaire that covered the degree, age of onset, progres-
sion and symmetry of hearing loss, as well as pathological
changes in the ear, infection, ototoxicity, noise exposure, and
other relevant clinical manifestations to understand the oto-
logic manifestations and to exclude any history of other dis-
eases and environmental factors. The proband underwent a
number of clinical tests including physical examinations,
hearing tests, chest X-rays, brain MRI, and temporal bone CT
scans. Hearing test included acoustic immittance, pure tone
audiometry and auditory brainstem response (ABR).2.3. Genetic analysesFor genetic analyses, peripheral blood was collected from
the proband and his parents. All genomic DNAs were
extracted using a blood DNA extraction kit following the
protocol provided by the manufacturer (TianGen, Beijing,
China). The coding region of POU3F4 was amplified fordirect sequencing using three sets of primers: 1) forward
primer 50-ACTTCCTGCTTGGGTCTCATTG-30 and reverse
primer 50-GGAGTGATCCTGGCAATGGT-30, 2) forward
primer 50-GGCACCGAACCCGTCTATC-30 and reverse
primer 50-TCCCCTGGCGGAGTCAT-30, 3) forward primer
50-TTGGAGAAGGAAGTGGTGCG-30 and reverse primer 50-
CCCAGCTTGGACTGCTTAATGTA-30. PCR amplification
was performed in a total volume of 20 mL, including 2 mL of
10  buffer, 0.5 mL of deoxynucleotide triphosphates
(2.5 mmol/L), 0.5 mL of primer L (10 mmol/L), 0.5 mL of
primer R (10 mmol/L), 1 mL of DNA, 0.2 mL of Taq poly-
merase, and 15.3 mL of water. The PCR reaction began with
incubation at 95 C for 5 min, followed by 30 cycles of
denaturation for 45 s at 95 C, annealing for 45 s at 55 C, and
extension for 30 s at 72 C, and a final 5 min extension at
72 C. PCR products were resolved by gel electrophoresis to
confirm product amplification. Bidirectional sequences of
amplified fragments were determined using an automated
DNA sequencer (ABI 3700XL Genetic Analyzer) and Bigdye
terminator v3.1 cycle sequencing kits (Applied Biosystems,
Foster City, CA, USA). Nucleotide alteration was identified by
sequence alignment with the POU3F4 Genbank sequence
(Genbank ID: NP_000298.3) using the Genetool software.
Mutations in the common deafness genes GJB2, SLC26A4 and
mtDNA 12S rRNAwere ruling out by sequencing the proband.
3. Results3.1. Clinical manifestations in the probandThe questionnaire answers revealed that the proband was
diagnosed with severe hearing loss when he was born, and his
parents were normal, denying a family history of hearing loss.
Acoustic immittance showed type A tympanograms in both
ears and static compliances of 0.49 ml and 0.40 ml for left and
right ear, respectively. Acoustic reflex was absent at 0.5, 1, 2
and 4 kHz. Auditory brainstem responses were absent for both
ears at 100 dB nHL. Pure-tone thresholds in the proband
showed profound sensorineural hearing loss without conduc-
tive component (Fig. 1). Temporal bone CT scans showed
bilateral cochlear incomplete partition, vestibule dysplasia,
internal auditory canal fundus dilation, and cochlear interlink
with the internal auditory canal fundus (Fig. 2), highly
consistent with features of DNFX2.3.2. Mutation screening of POU3F4Mutation screening of POU3F4 revealed a hemizygotic
C > A transversion at nucleotide 530 in the proband. This
mutation led to a stop codon at amino acid 177 out of 361
amino acids, p.S177X. C/A heterozygotes at nucleotide posi-
tion 530 were detected in the proband's mother. Sequence
variations in the family are shown in Fig. 3. The mutated
genotype was consistently cosegregated with the deafness
phenotype in the family. This mutation was confirmed to be a
novel mutation after searching relevant databases and
literatures.
Fig. 1. Audiogram of the proband.
Fig. 3. Sequence variations in the family. (A) Wild type found in the father. (B)
Heterozygous c.530C > A mutation found in the mother. (C) Hemizygotic
c.530C > A mutation detected in the male proband.
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We identified a novel mutation in the POU3F4 gene in a
Chinese family displaying X-linked inheritance of hearing
loss. This mutation results in a codon TCG change to the
terminator codon TAG at amino acid 177, which leads to
production of truncated proteins.
POU3F4 belongs to a superfamily of POU domain tran-
scription factors. The superfamily contains a typical structure
e a POU-specific domain and a POU homeodomain, both of
which are helix-turn-helix structural motifs that influence
DNA binding and specificity. The POU3F4 protein contains
361 amino acids, including the POU-specific domain with a
length of 67 amino acids (from Lys194 to Asp260), a linker of
15 residues (from Ser261 to Gln275), and a POU homeo-
domain with a length of 60 amino acids (from Gly276 toFig. 2. Temporal bone CT scan of the proband.
Fig. 4. The full-length and predicted truncated forms of human POU3F4 protein.
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revealed that the POU-specific domain and the POU homeo-
domain contain 4 and 3 a-helices, respectively (Klemm et al.,
1994).
As shown in this study, the mutation at the position of 177
leads to the production of truncated proteins, which do not
contain POU-specific domain or POU homeodomain (Fig. 4).
We speculate that the truncated protein has lost the function of
POU3F4. The proband in this study showed sensorineuralTable 1
Overview of POU3F4 mutations described in DFNX2, including the mutation
in the present study.
Mutation Position
of mutation
Feature
of deafness
References
S177X U SNHL This report
W67X U SNHL Cremers et al. (2000)
Q79X U SNHL Parzefall et al. (2013)
S98X U Mixed Marlin et al. (2009)
W114X U Mixed Waryah et al. (2011)
A116fs U Mixed Lee et al. (2009a)
G128fs U SNHL Lee et al. (2009b)
Q136X U Mixed Waryah et al. (2011)
R167X U SNHL Stankovic et al. (2010)
F201/K202del S Mixed Hagiwara et al. (1998)
K202fs S SNHL de Kok et al. (1995a)
L208fs S SNHL Lee et al. (2009b)
T211M S NA Choi et al. (2013)
R215fs S Mixed de Kok et al. (1995a)
G216E S SNHL Li et al. (2010)
S228L S SNHL Vore et al. (2005)
E229R S NA Choi et al. (2013)
T230I S Mixed Friedman et al. (1997)
I285R fsX43 H NA Parzefall et al. (2013)
E286fs H Mixed Cremers et al. (2000)
S288Q fsX37 H Mixed Bitner-Glindzicz et al. (1995)
L298fs H Mixed de Kok et al. (1995a)
P303S H Mixed Cremers et al. (2000)
I308N H Mixed Marlin et al. (2009)
S309P H SNHL Wang et al. (2006)
S310del H Mixed Lee et al. (2009b)
A312V H SNHL Bitner-Glindzicz et al. (1995)
L317F fsX12 H NA Choi et al. (2013)
L317W H Mixed de Kok et al. (1995a)
R323G H Mixed de Kok et al. (1997)
W325R H SNHL Schild et al. (2011)
N328T H Mixed Cremers et al. (2000)
R329G H Mixed Friedman et al. (1997)
R329P H Mixed Lee et al. (2009b)
R330S H SNHL de Kok et al. (1995a)
K334E H Mixed de Kok et al. (1995a)
T354E fx115 L NA Choi et al. (2013)
X362R extX113 L NA Choi et al. (2013)
*H, S, U and L indicate POU homeodomain, POU-specific domain, upstream
and downstream of the POU-domains, respectively; SNHL, sensorineural
hearing loss; Mixed, mixed hearing loss; NA, not available; fs, frameshift.hearing loss with bilateral cochlear incomplete partition,
vestibule dysplasia, internal auditory canal fundus dilation and
cochlear interlink with the internal auditory canal fundus, all
consistent with mutation in POU3F4. We speculate that the
c.530C > A mutation in POU3F4 produces truncated proteins
without the function of POU transcription factor, which leads
to the phenotype seen in the proband.
To date, dozens of pathological mutations have been found
in the POU3F4 gene, including mainly missense, insertion and
deletion mutations. Most of these mutations occur in the POU-
specific domain and POU homeodomain, and only a few in
upstream of the POU structure (Table 1). This indicates that
POU-specific domain and POU homeodomain are important
for POU3F4. Patients with POU3F4 mutations demonstrate
mainly mixed deafness or sensorineural hearing loss. In this
study, we found sensorineural hearing loss in a patient with the
novel mutation. Our finding expands the mutational spectrum
of human POU3F4.
The POU3F4 gene is the first cloned hereditary non-syn-
dromic hearing loss gene by De Kok et al in 1995 (de Kok
et al., 1995a)
In summary, we report the clinical and genetic character-
istics of a Chinese with X-linked non-syndromic sensorineural
deafness. DNA sequencing of the POU3F4 gene revealed a
novel nucleotide variation, c.530C > A (p.S177X), adding an
additional mutation in DFNX2.
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